[P15(INK4B) gene methylation in malignant hematopoietic diseases]

Zhonghua Xue Ye Xue Za Zhi. 2000 Dec;21(12):644-6.
[Article in Chinese]

Abstract

Objective: To study the effect of operative region hypermethylation gene in human malignant hematopoietic tumors.

Methods: The abnormal methylation rate of P(15)(INK4B) gene 5'CpG island in 68 cases of malignant hematopoietic tumor samples were determined by methylation specific PCR using bisulfite modified DNA.

Results: The methylation rates of P(15)(INK4B) were 84%, 0, 50% and 75%, respectively, for 25 cases of acute myeloid leukemia (AML), 15 chronic myeloid leukemia (CML), 16 myelodysplastic syndrome (MDS) and 12 multiple myeloma (MM). P(15)(INK4B) gene was frequently methylated in patients with high risk MDS and early stage of MM.

Conclusion: Hypermethylation of P(15)(INK4B) gene is one of the main causes of its inactivation. Hypermethylation of CpG island was closely related to the development of malignant hematopoietic diseases.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Cell Cycle Proteins / genetics*
  • CpG Islands / genetics
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • DNA Methylation*
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / metabolism
  • Female
  • Hematologic Neoplasms / genetics*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myeloid / genetics
  • Male
  • Middle Aged
  • Multiple Myeloma / genetics
  • Myelodysplastic Syndromes / genetics
  • Tumor Suppressor Proteins*

Substances

  • CDKN2B protein, human
  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Neoplasm
  • Tumor Suppressor Proteins